Veracyte Inc at UBS Global Healthcare Conference Transcript
Great. So welcome. First day of the UBS Global Healthcare Conference 2019. My name is Dan Brennan. I cover life science tools, diagnostics and pharma services. Pleased to be joined here on stage with the senior management team of Veracyte. To my left, Bonnie Anderson, Chairman and CEO; and to her left, Keith Kennedy, Chief Financial Officer.
Before we start, please go to www.ubs.com for all disclaimers. I think Bonnie and Keith are going to go through abbreviated presentation, given many of the investor base might be reasonably new to the story, then we'll go into Q&A.
And just as a precursor, my predecessor from eons ago, I was actually involved with taking Bonnie and Veracyte public, so I did a lot of diligence on the company back then. And certainly, for a company that couldn't get a 2 or 3x multiples, certainly things have gone well with you executing the strategy. So kudos to you. And with that,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |